| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Internship and Residency | 10 | 2021 | 47 | 3.610 |
Why?
|
| Obstetrics | 12 | 2024 | 18 | 3.130 |
Why?
|
| Pregnancy | 48 | 2024 | 417 | 2.810 |
Why?
|
| Gynecology | 10 | 2024 | 19 | 2.570 |
Why?
|
| Female | 60 | 2024 | 2964 | 2.310 |
Why?
|
| Humans | 66 | 2024 | 4931 | 2.120 |
Why?
|
| Pregnancy Outcome | 17 | 2024 | 28 | 1.880 |
Why?
|
| Adult | 35 | 2024 | 1402 | 1.560 |
Why?
|
| Students, Medical | 5 | 2022 | 30 | 1.460 |
Why?
|
| Retrospective Studies | 20 | 2023 | 513 | 1.440 |
Why?
|
| Pregnancy Complications | 4 | 2019 | 24 | 1.330 |
Why?
|
| Infant, Newborn | 20 | 2024 | 121 | 1.250 |
Why?
|
| Hypertension | 6 | 2024 | 123 | 1.200 |
Why?
|
| Infant, Newborn, Diseases | 4 | 2018 | 7 | 1.190 |
Why?
|
| Quality Improvement | 2 | 2019 | 27 | 1.140 |
Why?
|
| Patient Safety | 2 | 2019 | 8 | 1.020 |
Why?
|
| Diabetes, Gestational | 3 | 2016 | 12 | 0.920 |
Why?
|
| California | 10 | 2021 | 161 | 0.900 |
Why?
|
| Ultrasonography, Prenatal | 7 | 2010 | 15 | 0.840 |
Why?
|
| Cesarean Section | 4 | 2024 | 12 | 0.820 |
Why?
|
| Physicians | 2 | 2021 | 37 | 0.720 |
Why?
|
| Attitude of Health Personnel | 4 | 2020 | 25 | 0.710 |
Why?
|
| Antihypertensive Agents | 4 | 2024 | 48 | 0.710 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2017 | 9 | 0.700 |
Why?
|
| Simulation Training | 1 | 2020 | 3 | 0.700 |
Why?
|
| Students, Nursing | 1 | 2020 | 2 | 0.700 |
Why?
|
| Delivery, Obstetric | 6 | 2024 | 14 | 0.690 |
Why?
|
| Education, Medical, Undergraduate | 3 | 2020 | 16 | 0.680 |
Why?
|
| Adolescent | 10 | 2017 | 569 | 0.670 |
Why?
|
| Case-Control Studies | 10 | 2018 | 70 | 0.670 |
Why?
|
| Birth Weight | 5 | 2007 | 29 | 0.660 |
Why?
|
| Eclampsia | 2 | 2013 | 2 | 0.640 |
Why?
|
| Male | 14 | 2024 | 2620 | 0.640 |
Why?
|
| Curriculum | 5 | 2024 | 44 | 0.640 |
Why?
|
| Pre-Eclampsia | 5 | 2024 | 9 | 0.620 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2017 | 34 | 0.620 |
Why?
|
| Interprofessional Relations | 3 | 2020 | 11 | 0.610 |
Why?
|
| Cardiotocography | 2 | 2018 | 4 | 0.610 |
Why?
|
| Heart Rate, Fetal | 2 | 2018 | 20 | 0.600 |
Why?
|
| Risk Factors | 10 | 2016 | 593 | 0.600 |
Why?
|
| Young Adult | 9 | 2024 | 382 | 0.580 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 2 | 2012 | 2 | 0.580 |
Why?
|
| Pregnancy Complications, Cardiovascular | 4 | 2024 | 5 | 0.570 |
Why?
|
| Faculty | 2 | 2014 | 10 | 0.550 |
Why?
|
| Multiple Sclerosis | 1 | 2017 | 3 | 0.550 |
Why?
|
| Fetal Macrosomia | 1 | 2016 | 2 | 0.530 |
Why?
|
| School Admission Criteria | 1 | 2016 | 2 | 0.520 |
Why?
|
| Hypoglycemia | 1 | 2016 | 29 | 0.520 |
Why?
|
| Fetal Membranes, Premature Rupture | 3 | 2014 | 3 | 0.520 |
Why?
|
| Interviews as Topic | 1 | 2016 | 50 | 0.510 |
Why?
|
| Logistic Models | 8 | 2013 | 117 | 0.510 |
Why?
|
| Minority Groups | 3 | 2013 | 53 | 0.500 |
Why?
|
| Gestational Age | 5 | 2024 | 39 | 0.490 |
Why?
|
| Personality | 2 | 2014 | 3 | 0.480 |
Why?
|
| Middle Aged | 8 | 2023 | 1544 | 0.480 |
Why?
|
| Fetal Growth Retardation | 2 | 2023 | 35 | 0.480 |
Why?
|
| Embolism, Amniotic Fluid | 1 | 2014 | 1 | 0.450 |
Why?
|
| Emotional Intelligence | 1 | 2014 | 1 | 0.450 |
Why?
|
| Obstetrical Forceps | 1 | 2014 | 2 | 0.450 |
Why?
|
| Vacuum Extraction, Obstetrical | 1 | 2014 | 3 | 0.440 |
Why?
|
| Birth Injuries | 1 | 2014 | 4 | 0.440 |
Why?
|
| Postpartum Hemorrhage | 2 | 2014 | 2 | 0.440 |
Why?
|
| Cytomegalovirus Infections | 1 | 2014 | 2 | 0.440 |
Why?
|
| Pregnancy in Diabetics | 1 | 2013 | 6 | 0.430 |
Why?
|
| Racism | 3 | 2024 | 32 | 0.420 |
Why?
|
| Education, Medical | 2 | 2024 | 18 | 0.410 |
Why?
|
| Clinical Competence | 4 | 2020 | 46 | 0.410 |
Why?
|
| Pregnancy Complications, Hematologic | 2 | 2003 | 2 | 0.400 |
Why?
|
| Thrombophilia | 2 | 2003 | 2 | 0.400 |
Why?
|
| Practice Guidelines as Topic | 2 | 2011 | 69 | 0.390 |
Why?
|
| Personality Assessment | 1 | 2011 | 6 | 0.370 |
Why?
|
| Incidence | 5 | 2014 | 141 | 0.370 |
Why?
|
| Educational Measurement | 3 | 2007 | 17 | 0.360 |
Why?
|
| Fetal Diseases | 2 | 2001 | 9 | 0.350 |
Why?
|
| Episiotomy | 2 | 2010 | 3 | 0.350 |
Why?
|
| Lacerations | 2 | 2010 | 4 | 0.350 |
Why?
|
| Prevalence | 4 | 2017 | 184 | 0.340 |
Why?
|
| Mentors | 1 | 2010 | 14 | 0.330 |
Why?
|
| Faculty, Medical | 1 | 2010 | 16 | 0.330 |
Why?
|
| Hospitals | 1 | 2010 | 14 | 0.330 |
Why?
|
| Prospective Studies | 6 | 2017 | 229 | 0.330 |
Why?
|
| Postpartum Period | 3 | 2024 | 9 | 0.330 |
Why?
|
| Obstetric Labor, Premature | 3 | 2007 | 9 | 0.330 |
Why?
|
| Hospital Mortality | 1 | 2010 | 30 | 0.330 |
Why?
|
| Morbidity | 3 | 2014 | 17 | 0.320 |
Why?
|
| Infant, Premature | 3 | 2005 | 9 | 0.320 |
Why?
|
| Cohort Studies | 3 | 2020 | 224 | 0.320 |
Why?
|
| Observation | 1 | 2009 | 2 | 0.310 |
Why?
|
| Physician-Patient Relations | 1 | 2009 | 18 | 0.310 |
Why?
|
| Nurse's Role | 1 | 2009 | 13 | 0.300 |
Why?
|
| Teaching | 2 | 2010 | 10 | 0.300 |
Why?
|
| Placenta | 3 | 2023 | 37 | 0.300 |
Why?
|
| Heart Rate | 4 | 2003 | 25 | 0.290 |
Why?
|
| Foreign Medical Graduates | 1 | 2007 | 1 | 0.280 |
Why?
|
| Career Choice | 1 | 2007 | 12 | 0.280 |
Why?
|
| Education, Medical, Graduate | 1 | 2007 | 21 | 0.280 |
Why?
|
| Schools, Medical | 2 | 2022 | 16 | 0.280 |
Why?
|
| Internet | 1 | 2007 | 22 | 0.280 |
Why?
|
| Vulvar Neoplasms | 1 | 2007 | 2 | 0.270 |
Why?
|
| Pulmonary Edema | 1 | 2007 | 3 | 0.270 |
Why?
|
| Adenosine | 3 | 1995 | 8 | 0.270 |
Why?
|
| Zika Virus Infection | 2 | 2017 | 3 | 0.270 |
Why?
|
| Zika Virus | 2 | 2017 | 3 | 0.270 |
Why?
|
| Mental Disorders | 2 | 2013 | 43 | 0.270 |
Why?
|
| Chorioamnionitis | 2 | 2023 | 4 | 0.270 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2006 | 5 | 0.250 |
Why?
|
| Antibodies, Antiphospholipid | 2 | 2003 | 2 | 0.250 |
Why?
|
| Lipoprotein(a) | 2 | 2003 | 3 | 0.250 |
Why?
|
| Infant, Premature, Diseases | 1 | 2005 | 2 | 0.250 |
Why?
|
| Betamethasone | 1 | 2005 | 4 | 0.250 |
Why?
|
| Glucocorticoids | 1 | 2005 | 42 | 0.240 |
Why?
|
| Hypoxia | 2 | 1995 | 30 | 0.240 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2016 | 4 | 0.240 |
Why?
|
| Oligohydramnios | 2 | 2002 | 12 | 0.240 |
Why?
|
| Academic Dissertations as Topic | 1 | 2005 | 3 | 0.230 |
Why?
|
| Los Angeles | 4 | 2007 | 244 | 0.230 |
Why?
|
| Clinical Clerkship | 1 | 2005 | 17 | 0.230 |
Why?
|
| Nifedipine | 1 | 2024 | 2 | 0.230 |
Why?
|
| Labetalol | 1 | 2024 | 2 | 0.230 |
Why?
|
| Medication Adherence | 1 | 2024 | 36 | 0.220 |
Why?
|
| Primary Health Care | 1 | 2005 | 64 | 0.220 |
Why?
|
| Gender Identity | 1 | 2024 | 11 | 0.220 |
Why?
|
| Predictive Value of Tests | 4 | 2011 | 93 | 0.220 |
Why?
|
| Cocaine | 1 | 2004 | 21 | 0.220 |
Why?
|
| Premature Birth | 1 | 2023 | 4 | 0.210 |
Why?
|
| Sexual Behavior | 1 | 2024 | 49 | 0.210 |
Why?
|
| Sexual and Gender Minorities | 1 | 2024 | 20 | 0.210 |
Why?
|
| Academic Medical Centers | 2 | 2016 | 17 | 0.210 |
Why?
|
| HIV Infections | 1 | 2006 | 167 | 0.210 |
Why?
|
| Breast Feeding | 1 | 2023 | 12 | 0.210 |
Why?
|
| Uterine Contraction | 1 | 2003 | 3 | 0.210 |
Why?
|
| Prenatal Diagnosis | 1 | 2003 | 6 | 0.210 |
Why?
|
| Treatment Outcome | 4 | 2024 | 402 | 0.200 |
Why?
|
| Thromboembolism | 1 | 2003 | 3 | 0.200 |
Why?
|
| Cooperative Behavior | 2 | 2020 | 24 | 0.200 |
Why?
|
| Fetus | 3 | 2023 | 114 | 0.190 |
Why?
|
| Amniotic Fluid | 1 | 2002 | 40 | 0.190 |
Why?
|
| Blood Pressure | 5 | 2024 | 98 | 0.190 |
Why?
|
| Abdominal Muscles | 1 | 2001 | 1 | 0.180 |
Why?
|
| Gastroschisis | 1 | 2001 | 1 | 0.180 |
Why?
|
| Intestinal Atresia | 1 | 2001 | 2 | 0.180 |
Why?
|
| Hernia, Hiatal | 1 | 2001 | 1 | 0.180 |
Why?
|
| Bias | 1 | 2021 | 5 | 0.180 |
Why?
|
| Personnel, Hospital | 1 | 2021 | 2 | 0.180 |
Why?
|
| Hymen | 1 | 2001 | 1 | 0.180 |
Why?
|
| Ureterocele | 1 | 2001 | 1 | 0.180 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2001 | 2 | 0.180 |
Why?
|
| Patient Care Team | 2 | 2012 | 12 | 0.180 |
Why?
|
| Prejudice | 1 | 2021 | 15 | 0.180 |
Why?
|
| Education, Nursing | 1 | 2020 | 2 | 0.180 |
Why?
|
| Diseases in Twins | 1 | 2000 | 5 | 0.170 |
Why?
|
| Ileum | 1 | 2000 | 5 | 0.170 |
Why?
|
| Intestinal Obstruction | 1 | 2000 | 3 | 0.170 |
Why?
|
| Congenital Abnormalities | 1 | 2000 | 5 | 0.170 |
Why?
|
| Hypertension, Pregnancy-Induced | 3 | 2024 | 5 | 0.170 |
Why?
|
| Pilot Projects | 2 | 2014 | 53 | 0.160 |
Why?
|
| Models, Educational | 1 | 2019 | 4 | 0.160 |
Why?
|
| Fetal Death | 1 | 1998 | 5 | 0.150 |
Why?
|
| Rural Health | 1 | 1998 | 2 | 0.150 |
Why?
|
| Perineum | 2 | 2010 | 4 | 0.150 |
Why?
|
| Weight Gain | 1 | 1998 | 27 | 0.150 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2018 | 4 | 0.150 |
Why?
|
| Infant, Small for Gestational Age | 3 | 2024 | 5 | 0.140 |
Why?
|
| Body Mass Index | 1 | 1998 | 127 | 0.140 |
Why?
|
| Organizational Culture | 1 | 2017 | 2 | 0.140 |
Why?
|
| Michigan | 1 | 2017 | 5 | 0.140 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 92 | 0.130 |
Why?
|
| Isoleucine | 1 | 2016 | 1 | 0.130 |
Why?
|
| Metabolomics | 1 | 2016 | 2 | 0.130 |
Why?
|
| Pregnancy Trimester, First | 1 | 2016 | 2 | 0.130 |
Why?
|
| Leucine | 1 | 2016 | 2 | 0.130 |
Why?
|
| Valine | 1 | 2016 | 2 | 0.130 |
Why?
|
| Regression Analysis | 1 | 2016 | 59 | 0.130 |
Why?
|
| Personnel Selection | 1 | 2016 | 2 | 0.130 |
Why?
|
| Length of Stay | 2 | 2010 | 34 | 0.130 |
Why?
|
| Fetal Development | 1 | 2016 | 21 | 0.130 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1995 | 21 | 0.120 |
Why?
|
| Fetal Blood | 1 | 1995 | 41 | 0.120 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2014 | 2 | 0.110 |
Why?
|
| Immunoassay | 1 | 2014 | 3 | 0.110 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 179 | 0.110 |
Why?
|
| Developing Countries | 1 | 2014 | 27 | 0.110 |
Why?
|
| Social Perception | 1 | 2014 | 2 | 0.110 |
Why?
|
| Self-Assessment | 1 | 2014 | 4 | 0.110 |
Why?
|
| Vacuum | 1 | 2014 | 1 | 0.110 |
Why?
|
| Interpersonal Relations | 1 | 2014 | 13 | 0.110 |
Why?
|
| Self Concept | 1 | 2014 | 9 | 0.110 |
Why?
|
| Data Collection | 1 | 2014 | 27 | 0.110 |
Why?
|
| Urban Population | 2 | 2005 | 64 | 0.110 |
Why?
|
| Social Behavior | 1 | 2014 | 12 | 0.110 |
Why?
|
| Serologic Tests | 1 | 2014 | 1 | 0.110 |
Why?
|
| Antibodies, Neutralizing | 1 | 2014 | 3 | 0.110 |
Why?
|
| Antibodies, Viral | 1 | 2014 | 6 | 0.110 |
Why?
|
| DNA, Viral | 1 | 2014 | 7 | 0.110 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 10 | 0.110 |
Why?
|
| Hospital Volunteers | 1 | 2013 | 1 | 0.110 |
Why?
|
| Chronic Disease | 2 | 2024 | 135 | 0.110 |
Why?
|
| Burnout, Professional | 1 | 2013 | 8 | 0.110 |
Why?
|
| Risk | 1 | 2013 | 39 | 0.100 |
Why?
|
| Professional Role | 1 | 2012 | 4 | 0.100 |
Why?
|
| Infant Mortality | 2 | 2003 | 6 | 0.100 |
Why?
|
| Umbilical Arteries | 1 | 1992 | 2 | 0.100 |
Why?
|
| Fetal Distress | 1 | 1992 | 4 | 0.100 |
Why?
|
| New Jersey | 2 | 2003 | 4 | 0.090 |
Why?
|
| Expressed Emotion | 1 | 2011 | 1 | 0.090 |
Why?
|
| Infant, Low Birth Weight | 2 | 2004 | 2 | 0.090 |
Why?
|
| Glucose Tolerance Test | 1 | 2011 | 38 | 0.090 |
Why?
|
| United States | 2 | 2022 | 764 | 0.090 |
Why?
|
| Job Satisfaction | 1 | 2010 | 3 | 0.080 |
Why?
|
| Preceptorship | 1 | 2010 | 4 | 0.080 |
Why?
|
| Hospitals, Rural | 1 | 2010 | 1 | 0.080 |
Why?
|
| Placenta, Retained | 1 | 2010 | 1 | 0.080 |
Why?
|
| Hospitals, Public | 1 | 2010 | 3 | 0.080 |
Why?
|
| Hospitals, Private | 1 | 2010 | 2 | 0.080 |
Why?
|
| Hospitals, Teaching | 1 | 2010 | 6 | 0.080 |
Why?
|
| Hospital Costs | 1 | 2010 | 7 | 0.080 |
Why?
|
| Databases, Factual | 1 | 2010 | 60 | 0.080 |
Why?
|
| Feedback | 1 | 2009 | 12 | 0.080 |
Why?
|
| Apgar Score | 2 | 2003 | 4 | 0.080 |
Why?
|
| Nursing Staff, Hospital | 1 | 2009 | 8 | 0.080 |
Why?
|
| Animals | 4 | 2016 | 1369 | 0.080 |
Why?
|
| Ultrasonography | 2 | 2002 | 23 | 0.070 |
Why?
|
| Biomarkers | 2 | 2021 | 160 | 0.070 |
Why?
|
| Emigration and Immigration | 1 | 2007 | 6 | 0.070 |
Why?
|
| Teaching Materials | 1 | 2007 | 2 | 0.070 |
Why?
|
| Software | 1 | 2007 | 16 | 0.070 |
Why?
|
| Parity | 1 | 2007 | 5 | 0.070 |
Why?
|
| Reference Values | 1 | 2007 | 41 | 0.070 |
Why?
|
| Analgesia, Obstetrical | 1 | 2006 | 2 | 0.070 |
Why?
|
| Analgesia, Epidural | 1 | 2006 | 4 | 0.070 |
Why?
|
| Sheep | 3 | 1995 | 130 | 0.070 |
Why?
|
| Sex Factors | 1 | 2007 | 120 | 0.070 |
Why?
|
| Prognosis | 1 | 2007 | 167 | 0.060 |
Why?
|
| Theophylline | 2 | 1995 | 2 | 0.060 |
Why?
|
| Purinergic P1 Receptor Antagonists | 2 | 1995 | 2 | 0.060 |
Why?
|
| Smoking | 2 | 1998 | 59 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 126 | 0.060 |
Why?
|
| Medicine | 1 | 2005 | 10 | 0.060 |
Why?
|
| Credentialing | 1 | 2004 | 1 | 0.060 |
Why?
|
| Specialization | 1 | 2005 | 14 | 0.060 |
Why?
|
| Research | 1 | 2005 | 21 | 0.060 |
Why?
|
| Arterial Pressure | 1 | 2024 | 2 | 0.060 |
Why?
|
| Random Allocation | 1 | 2004 | 18 | 0.060 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2004 | 2 | 0.060 |
Why?
|
| Maternal Age | 1 | 2004 | 2 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2024 | 36 | 0.060 |
Why?
|
| Syphilis | 1 | 2004 | 4 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2004 | 9 | 0.060 |
Why?
|
| Sexism | 1 | 2024 | 4 | 0.060 |
Why?
|
| Linear Models | 1 | 2004 | 34 | 0.060 |
Why?
|
| Alcoholism | 1 | 2004 | 17 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 77 | 0.050 |
Why?
|
| Medically Underserved Area | 1 | 2004 | 36 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2004 | 76 | 0.050 |
Why?
|
| Bradycardia | 1 | 2023 | 2 | 0.050 |
Why?
|
| Time Factors | 1 | 2024 | 245 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2004 | 146 | 0.050 |
Why?
|
| Infant | 1 | 2023 | 132 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 45 | 0.050 |
Why?
|
| African Americans | 1 | 2006 | 256 | 0.050 |
Why?
|
| Blood Coagulation Disorders | 1 | 2003 | 4 | 0.050 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2003 | 6 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2003 | 7 | 0.050 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2003 | 1 | 0.050 |
Why?
|
| Factor V | 1 | 2003 | 1 | 0.050 |
Why?
|
| Pregnancy Trimesters | 1 | 2003 | 1 | 0.050 |
Why?
|
| Prothrombin | 1 | 2003 | 1 | 0.050 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2003 | 1 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 31 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 66 | 0.050 |
Why?
|
| Mutation | 1 | 2003 | 51 | 0.050 |
Why?
|
| Intensive Care, Neonatal | 1 | 2002 | 2 | 0.050 |
Why?
|
| Survival Rate | 1 | 2002 | 92 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 69 | 0.050 |
Why?
|
| Cytosine | 1 | 2021 | 2 | 0.050 |
Why?
|
| CpG Islands | 1 | 2021 | 4 | 0.050 |
Why?
|
| Short Bowel Syndrome | 1 | 2001 | 1 | 0.050 |
Why?
|
| Intestines | 1 | 2001 | 4 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2001 | 6 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2021 | 14 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2001 | 4 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 25 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2001 | 45 | 0.040 |
Why?
|
| Occupational Stress | 1 | 2021 | 3 | 0.040 |
Why?
|
| Hydronephrosis | 1 | 2001 | 1 | 0.040 |
Why?
|
| Anxiety | 1 | 2021 | 32 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2021 | 41 | 0.040 |
Why?
|
| Medical Records | 1 | 2000 | 21 | 0.040 |
Why?
|
| Pandemics | 1 | 2021 | 65 | 0.040 |
Why?
|
| Depression | 1 | 2021 | 97 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 358 | 0.040 |
Why?
|
| Twins | 1 | 1998 | 4 | 0.040 |
Why?
|
| Odds Ratio | 1 | 1998 | 67 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1995 | 28 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 2 | 0.030 |
Why?
|
| Aged | 1 | 2021 | 1188 | 0.030 |
Why?
|
| Aedes | 1 | 2016 | 1 | 0.030 |
Why?
|
| Insect Bites and Stings | 1 | 2016 | 1 | 0.030 |
Why?
|
| Microcephaly | 1 | 2016 | 2 | 0.030 |
Why?
|
| Travel | 1 | 2016 | 6 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 83 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 15 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 69 | 0.030 |
Why?
|
| Obesity | 1 | 1998 | 189 | 0.030 |
Why?
|
| Blood Flow Velocity | 2 | 1993 | 7 | 0.030 |
Why?
|
| Tromethamine | 1 | 1995 | 1 | 0.030 |
Why?
|
| Glycolysis | 1 | 1995 | 2 | 0.030 |
Why?
|
| Gases | 1 | 1995 | 3 | 0.030 |
Why?
|
| Acidosis | 1 | 1995 | 29 | 0.030 |
Why?
|
| Hemoglobins | 1 | 1995 | 30 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2014 | 13 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2014 | 81 | 0.030 |
Why?
|
| Private Practice | 1 | 2013 | 1 | 0.030 |
Why?
|
| Accreditation | 1 | 2013 | 3 | 0.030 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2013 | 10 | 0.030 |
Why?
|
| Pregnancy, Animal | 1 | 1993 | 14 | 0.030 |
Why?
|
| Uterus | 1 | 1993 | 12 | 0.030 |
Why?
|
| Fetal Monitoring | 1 | 1992 | 6 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2010 | 8 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2010 | 10 | 0.020 |
Why?
|
| Models, Biological | 1 | 2010 | 46 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1993 | 13 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1993 | 15 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1993 | 9 | 0.010 |
Why?
|
| Arteries | 1 | 1993 | 14 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1993 | 32 | 0.010 |
Why?
|
| Equipment Design | 1 | 1989 | 16 | 0.000 |
Why?
|
| Labor, Obstetric | 1 | 1989 | 14 | 0.000 |
Why?
|